Advertisement
UK markets close in 3 hours 30 minutes
  • FTSE 100

    8,088.20
    +43.39 (+0.54%)
     
  • FTSE 250

    19,805.59
    +5.87 (+0.03%)
     
  • AIM

    755.07
    +0.20 (+0.03%)
     
  • GBP/EUR

    1.1633
    +0.0005 (+0.04%)
     
  • GBP/USD

    1.2436
    -0.0016 (-0.13%)
     
  • Bitcoin GBP

    53,542.07
    +434.67 (+0.82%)
     
  • CMC Crypto 200

    1,437.96
    +13.86 (+0.97%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.08
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,328.20
    -13.90 (-0.59%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,191.64
    +53.99 (+0.30%)
     
  • CAC 40

    8,137.65
    +31.87 (+0.39%)
     

Trinseo Full Year 2022 Earnings: US$11.92 loss per share (vs US$7.23 profit in FY 2021)

Trinseo (NYSE:TSE) Full Year 2022 Results

Key Financial Results

  • Revenue: US$4.97b (up 2.9% from FY 2021).

  • Net loss: US$428.0m (down by 253% from US$279.6m profit in FY 2021).

  • US$11.92 loss per share (down from US$7.23 profit in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Trinseo Earnings Insights

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 3.3% growth forecast for the Chemicals industry in the US.

Performance of the American Chemicals industry.

The company's shares are down 2.1% from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for Trinseo that you need to take into consideration.

ADVERTISEMENT

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here